These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15322944)

  • 61. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.
    Ranque B; Bérezné A; Le-Guern V; Pagnoux C; Allanore Y; Launay D; Hachulla E; Authier FJ; Gherardi R; Kahan A; Cabane J; Guillevin L; Mouthon L
    Scand J Rheumatol; 2010 Nov; 39(6):498-505. PubMed ID: 20726682
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interstitial lung disease in scleroderma.
    White B
    Rheum Dis Clin North Am; 2003 May; 29(2):371-90. PubMed ID: 12841300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.
    Paik JJ; Wigley FM; Lloyd TE; Corse AM; Casciola-Rosen L; Shah AA; Boin F; Hummers LK; Mammen AL
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1416-25. PubMed ID: 25989455
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia.
    Ashida R; Ihn H; Mimura Y; Jinnin M; Asano Y; Kubo M; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):781-3. PubMed ID: 19508567
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atypical systemic sclerosis of early onset.
    Davies MG; Warin AP; Liddell K
    Br J Dermatol; 1979 Jul; 101 Suppl 17():54-6. PubMed ID: 465340
    [No Abstract]   [Full Text] [Related]  

  • 68. [Muscle involvement in Systemic Sclerosis - diagnosis evaluation].
    Pinto L; Castelão W; Branco JC
    Acta Reumatol Port; 2010; 35(2):142-5. PubMed ID: 20711089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mediastinal lymphadenopathy preceding skin and lung fibrosis in systemic sclerosis.
    Yoshioka K
    Respiration; 1994; 61(3):169-71. PubMed ID: 8047722
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Skeletal muscle pathology in systemic sclerosis.
    Calore EE; Cavaliere MJ; Perez NM; Takayasu V; Wakamatsu A; Kiss MH
    J Rheumatol; 1995 Dec; 22(12):2246-9. PubMed ID: 8835557
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.
    Matas-García A; Guillén-Del-Castillo A; Kisluk B; Selva-O'Callaghan A; Espinosa G; Prieto-González S; Moreno Lozano P; Garrabou G; Grau-Junyent JM; Simeon-Aznar CP; Milisenda JC
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI82-SI90. PubMed ID: 35713496
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic measures for patients with systemic sclerosis-associated myopathy.
    Baumberger R; Jordan S; Distler O; Baschung Pfister P; Maurer B
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):85-93. PubMed ID: 34323680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastrointestinal involvement in patients with systemic sclerosis.
    Wielosz E; Borys O; Zychowska I; Majdan M
    Pol Arch Med Wewn; 2010 Apr; 120(4):132-6. PubMed ID: 20424538
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Muscle involvement in the scleroderma syndromes.
    Ringel RA; Brick JE; Brick JF; Gutmann L; Riggs JE
    Arch Intern Med; 1990 Dec; 150(12):2550-2. PubMed ID: 2244771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Scleroderma and environment. Cutaneous manifestations of toxic oil syndrome].
    Iglesias Diez L; Vanaclocha Sebastian F
    Ann Dermatol Venereol; 1991; 118(12):954-61. PubMed ID: 1799246
    [No Abstract]   [Full Text] [Related]  

  • 77. A case of sarcoidosis developing as sarcoid myopathy concomitant with systemic sclerosis and review of the literature.
    Ogane K; Kato T; Mizushima I; Kawano M; Yamagishi M
    Mod Rheumatol; 2012 Feb; 22(1):142-6. PubMed ID: 21674219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
    Moinzadeh P; Krieg T; Hellmich M; Brinckmann J; Neumann E; Müller-Ladner U; Kreuter A; Dumitrescu D; Rosenkranz S; Hunzelmann N
    Exp Dermatol; 2011 Sep; 20(9):770-3. PubMed ID: 21707759
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.